BioCentury

7:00 AM GMT, Jun 7, 2010
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

Linifanib: Phase II data

In an open-label Phase II trial in 53 patients who previously failed treatment with Sutent sunitinib, 0.25 mg/kg

Read the full 181 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.